AKT1 and cancer: We observed that MitoQ treatment effectively induced cancer cell death, inhibited cell migration, arrested cell cycle progression, and modulated the expression of phosphorylated AKT, ERK, and ROS-related genes in canine mammary tumor cells, specifically CMT-U27 and CF41.Mg cells.